Filters:
Investigator: Joseph Harding1 Projects | 1 Researchers | $174,993 Invested
2012
Athira Pharma Inc.
Joseph Harding, PhD
Development of small molecule hepatoctye growth factor mimetic for the treatment of dementia.
Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Joseph Harding, PhD
Development of small molecule hepatoctye growth factor mimetic for the treatment of dementia.